Martino Salvatore, Gargano Serena, Carollo Pietro Salvatore, Di Leonardo Aldo, Barra Viviana
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128, Palermo, Italy.
Centro Di Oncobiologia Sperimentale (C.O.B.S.), Viale Delle Scienze, 90128, Palermo, Italy.
Cell Mol Life Sci. 2024 Dec 18;82(1):7. doi: 10.1007/s00018-024-05547-y.
Methylation of cytosine in CpG dinucleotides is an epigenetic modification carried out by DNA-methyltransferases (DNMTs) that contributes to chromatin condensation and structure and, thus, to gene transcription regulation and chromosome stability. DNMT1 maintains the DNA methylation pattern of the genome at each cell cycle by copying it to the newly synthesized DNA strand during the S-phase. DNMT1 pharmacological inhibition as well as genetic knockout and knockdown, leads to passive DNA methylation loss. However, these strategies have been associated with different cell fates, even in the same cell background, suggesting that they can question the interpretation of the obtained results. Using a cell system in which endogenous DNMT1 is fused with an inducible degron and can be rapidly degraded, we found that in non-tumoral RPE-1 cells, DNMT1 loss progressively induced cell proliferation slowing-down and cell cycle arrest at the G1/S transition. The latter is due to p21 activation, which is partly mediated by p53 and leads to a global reduction in DNA methylation. DNMT1 restoration rescues cell proliferation, indicating that its deregulation is sensed as tunable cellular stress.
CpG二核苷酸中胞嘧啶的甲基化是一种由DNA甲基转移酶(DNMTs)进行的表观遗传修饰,它有助于染色质浓缩和结构形成,进而参与基因转录调控和染色体稳定性维持。DNMT1在每个细胞周期通过在S期将基因组的DNA甲基化模式复制到新合成的DNA链上来维持该模式。DNMT1的药理学抑制以及基因敲除和敲低都会导致被动性DNA甲基化丢失。然而,即使在相同的细胞背景下,这些策略也与不同的细胞命运相关,这表明它们可能会对所得结果的解释产生质疑。利用一种细胞系统,其中内源性DNMT1与一个可诱导的降解结构域融合且能被快速降解,我们发现在非肿瘤性RPE - 1细胞中,DNMT1缺失会逐渐导致细胞增殖减缓以及在G1/S期转换时细胞周期停滞。后者是由于p21激活所致,p21的激活部分由p53介导,并导致DNA甲基化整体减少。DNMT1的恢复可挽救细胞增殖,表明其失调被感知为可调节的细胞应激。